SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Weekly review: The omicron variant—the 'good,' 'bad,' and 'ugly' scenarios


Judge blocks Biden's mandate to health care workers, what we know (and still don't) about omicron, and more.

Omicron: The 3 biggest unanswered questions (Monday, November 29)

The newly discovered omicron variant has been labeled a "variant of concern" by the World Health Organization—but how serious will it ultimately be for public health? That will depend, experts say, on the still-unknown answers to these three key questions.

The omicron variant: The 'good,' 'bad,' and 'ugly' scenarios (Tuesday, November 30)

Since the news broke about the omicron variant, Advisory Board's Pamela Divack and Andrew Mohama pondered America's coronavirus future: What are the (relatively) "good," "bad," and "ugly" scenarios? In this piece, they've updated and mapped out the possibilities.

Judge blocks Biden's mandate to vaccinate health care workers (Wednesday, December 1)

A federal judge last week issued a nationwide injunction, blocking CMS' mandate requiring workers in most health care settings participating in Medicare and Medicaid to be fully vaccinated against Covid-19 by Jan. 4, arguing CMS doesn't have the authority to enact such a mandate.

Omicron: What we know (and still don't) about the new variant (Thursday, December 2)

The new omicron variant is "more of a Frankenstein" than previous virus coronavirus variants, according to one virologist, and vaccine experts are at odds over how well current vaccines will provide protection against it.

An omicron wave is coming—but will it be worse than delta? (Friday, December 3)

Omicron has become the most dominant coronavirus variant in South Africa, and at least nine omicron cases have now been reported in five U.S. states. But while an omicron surge is likely coming, experts say it's too early to know how this variant-driven wave might compare to others.

 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.